An rs4705342 T>C polymorphism in the promoter of miR-143/145 is associated with a decreased risk of ischemic stroke

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wei, Ye Sheng ^a   Xiang, Yang ^a   Liao, Pin Hu ^a   Wang, Jun Li ^a   Peng, You Fan ^a  

^a AFFILIATED HOSPITAL OF YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN143 MICRORNA, HUMAN; MIRN145 MICRORNA, HUMAN;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FEMALE; GENETICS; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

AGED; BRAIN ISCHEMIA; FEMALE; HAPLOTYPES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; STROKE;

EID: 84990831595     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34620     Document Type: Article

References (42)

1. Ross, R. Atherosclerosis-an inflammatory disease. The New England journal of medicine 340, 115-126, doi: 10.1056/ NEJM199901143400207 (1999).
2. Weber, C. & Noels, H. Atherosclerosis: current pathogenesis and therapeutic options. Nature medicine 17, 1410-1422, doi: 10.1038/ nm.2538 (2011).
3. Fromm, A., Haaland, O. A., Naess, H., Thomassen, L. & Waje-Andreassen, U. Atherosclerosis in Trial of Org 10172 in Acute Stroke Treatment Subtypes among Young and Middle-Aged Stroke Patients: The Norwegian Stroke in the Young Study. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association, doi: 10.1016/j.jstrokecerebrovasdis.2015.12.019 (2016).
4. Liu, L., Wang, D., Wong, K. S. & Wang, Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke; a journal of cerebral circulation 42, 3651-3654, doi: 10.1161/STROKEAHA.111.635755 (2011).
5. Shinton, R. & Beevers, G. Meta-analysis of relation between cigarette smoking and stroke. Bmj 298, 789-794 (1989).
6. Davis, P. H. et al. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Annals of neurology 22, 319-327, doi: 10.1002/ana.410220307 (1987).
7. Dichgans, M. Genetics of ischaemic stroke. The Lancet. Neurology 6, 149-161, doi: 10.1016/S1474-4422(07)70028-5 (2007).
8. MacClellan, L. R. et al. Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study. Genetic epidemiology 30, 602-608, doi: 10.1002/gepi.20171 (2006).
9. Brass, L. M., Isaacsohn, J. L., Merikangas, K. R. & Robinette, C. D. A study of twins and stroke. Stroke; a journal of cerebral circulation 23, 221-223 (1992).
10. Jia, L., Hao, F., Wang, W. & Qu, Y. Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients. Cell biochemistry and function 33, 314-319, doi: 10.1002/cbf.3116 (2015).
11. Gan, C. S., Wang, C. W. & Tan, K. S. Circulatory microRNA-145 expression is increased in cerebral ischemia. Genet Mol Res 11, 147-152, doi: 10.4238/2012.January.27.1 (2012).
12. Volny, O., Kasickova, L., Coufalova, D., Cimflova, P. & Novak, J. microRNAs in Cerebrovascular Disease. Advances in experimental medicine and biology 888, 155-195, doi: 10.1007/978-3-319-22671-2-9 (2015).
13. Koutsis, G., Siasos, G. & Spengos, K. The emerging role of microRNA in stroke. Curr Top Med Chem 13, 1573-1588 (2013).
14. Maitrias, P. et al. MicroRNA deregulation in symptomatic carotid plaque. Journal of vascular surgery 62, 1245-1250 e1241, doi: 10.1016/j.jvs.2015.06.136 (2015).
15. Rink, C. & Khanna, S. MicroRNA in ischemic stroke etiology and pathology. Physiological genomics 43, 521-528, doi: 10.1152/ physiolgenomics.00158.2010 (2011).
16. Dharap, A., Bowen, K., Place, R., Li, L. C. & Vemuganti, R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 29, 675-687, doi: 10.1038/jcbfm.2008.157 (2009).
17. Santulli, G. microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Advances in experimental medicine and biology 887, 53-77, doi: 10.1007/978- 3-319-22380-3-4 (2015).
18. Wei, Y., Nazari-Jahantigh, M., Neth, P., Weber, C. & Schober, A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arteriosclerosis, thrombosis, and vascular biology 33, 449-454, doi: 10.1161/ATVBAHA.112.300279 (2013).
19. Santovito, D. et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert opinion on therapeutic targets 17, 217-223, doi: 10.1517/14728222.2013.745512 (2013).
20. Fu, X., Guo, L., Jiang, Z. M., Zhao, L. S. & Xu, A. G. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med 7, 1813-1817 (2014).
21. Li, L. et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Human immunology 74, 993-997, doi: 10.1016/j.humimm.2013.04.019 (2013).
22. Li, L. et al. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol 34, 1919-1923, doi: 10.1007/s13277-013-0736-9 (2013).
23. Gao, L. B. et al. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem 394, 415-420, doi: 10.1515/hsz-2012-0297/j/bchm.just-accepted/hsz-2012-0297/hsz-2012-0297.xml [pii] (2013).
24. Li, L. et al. Interactions of miR-34b/c and TP53 Polymorphisms on the Risk of Intracranial Aneurysm. Clin Dev Immunol 2012, 567586, doi: 10.1155/2012/567586 (2012).
25. Wang, Y. et al. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study. Medicine 94, e1879, doi: 10.1097/MD.0000000000001879 (2015).
26. Liang, Y. et al. Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder. Journal of affective disorders 183, 295-299, doi: 10.1016/j.jad.2015.04.035 (2015).
27. Sima, X., Sun, H., Zhou, P. & You, C. A Potential Polymorphism in the Promoter of Let-7 is Associated With an Increased Risk of Intracranial Aneurysm: A Case-Control Study. Medicine 94, e2267, doi: 10.1097/MD.0000000000002267 (2015).
28. Chen, P. et al. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study. Medicine 94, e1536, doi: 10.1097/MD.0000000000001536 (2015).
29. Chu, H. et al. A functional variant in miR-143 promoter contributes to prostate cancer risk. Arch Toxicol 90, 403-414, doi: 10.1007/ s00204-014-1396-2 (2016).
30. Liang, Y. et al. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study. Medicine 94, e1289, doi: 10.1097/MD.0000000000001289 (2015).
31. Wei, Y. S., Lan, Y., Meng, L. Q. & Nong, L. G. The association of L-selectin polymorphisms with L-selectin serum levels and risk of ischemic stroke. Journal of thrombosis and thrombolysis 32, 110-115, doi: 10.1007/s11239-011-0587-4 (2011).
32. John, S. W., Weitzner, G., Rozen, R. & Scriver, C. R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic acids research 19, 408 (1991).
33. Sole, X., Guino, E., Valls, J., Iniesta, R. & Moreno, V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22, 1928-1929, doi: 10.1093/bioinformatics/btl268 (2006).
34. Vengrenyuk, Y. et al. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arteriosclerosis, thrombosis, and vascular biology 35, 535-546, doi: 10.1161/ ATVBAHA.114.304029 (2015).
35. Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes & development 23, 2166-2178, doi: 10.1101/gad.1842409 (2009).
36. Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. The Journal of clinical investigation 119, 2634-2647, doi: 10.1172/JCI38864 (2009).
37. Riches, K. et al. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. Journal of molecular and cellular cardiology 74, 240-250, doi: 10.1016/j. yjmcc.2014.05.018 (2014).
38. Sala, F. et al. MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice. Thrombosis and haemostasis 112, 796-802, doi: 10.1160/TH13-11-0905 (2014).
39. Gretarsdottir, S. et al. Localization of a susceptibility gene for common forms of stroke to 5q12. American journal of human genetics 70, 593-603, doi: 10.1086/339252 (2002).
40. Nilsson-Ardnor, S. et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke; a journal of cerebral circulation 36, 1666-1671, doi: 10.1161/01.STR.0000174188.04716.8d (2005).
41. Nilsson-Ardnor, S. et al. Genome-wide linkage scan of common stroke in families from northern Sweden. Stroke; a journal of cerebral circulation 38, 34-40, doi: 10.1161/01.STR.0000251643.37454.16 (2007).
42. Carty, C. L. et al. Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans. Stroke; a journal of cerebral circulation 46, 2063-2068, doi: 10.1161/STROKEAHA.115.009044 (2015).